Physician profile
Kexia Van
NPI 1154856151
$1,048.94
in general payments reported to CMS, 2019-2025
20 companies · $62.03 in 2025
The $62.03 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.93 · 2022: $873 · 2023: $41.94 · 2024: $31.26 · 2025: $62.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $135.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $275.19 | 2019-2025 | Wegovy |
| Abbvie INC. | $239.65 | 2022-2023 | Qulipta |
| Lilly USA, LLC | $105.95 | 2022-2025 | Mounjaro, Zepbound |
| Biohaven Pharmaceutical Holding Company Ltd. | $90.98 | 2022 | |
| Glaxosmithkline, LLC. | $49.15 | 2022 | |
| Pfizer INC. | $31.11 | 2022 | |
| Sanofi-Aventis U.S. LLC | $30.09 | 2022 | |
| Exact Sciences Corporation | $29.23 | 2024-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals Lp | $27.46 | 2022 | |
| Idorsia Pharmaceuticals US INC | $27.20 | 2022 | |
| Merck Sharp & Dohme LLC | $16.79 | 2022 | |
| Agios Pharmaceuticals, INC. | $16.66 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.10 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.72 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.08 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynavax Technologies Corporation | $13.58 | 2022 | |
| Amgen INC. | $12.94 | 2023 | Repatha, Otezla |
| Astellas Pharma US INC | $12.93 | 2022 | |
| Mylan Specialty L.P. | $12.12 | 2022 | |
| Eisai INC. | $11.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kexia Van listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.